# Infarct Size Reduction in an Anterior ST-Elevation Myocardial Infarction Following “Optimized” Supersaturated Oxygen Therapy

## TL;DR

A 37-year-old woman with a severe heart attack showed improved heart function and reduced damage after receiving a new oxygen therapy.

## Contribution

The paper presents a novel application of optimized supersaturated oxygen therapy in reducing infarct size after a heart attack.

## Key findings

- The patient showed enhanced left ventricular function after the therapy.
- There was a significant reduction in the size of the LV apical aneurysm.
- The therapy suggests potential benefits for myocardial salvage in severe MI cases.

## Abstract

This comprehensive case report documents the treatment of a 37-year-old female patient who presented with anterior ST-elevation myocardial infarction (STEMI). The patient underwent percutaneous coronary intervention (PCI), followed by an innovative therapy - optimized supersaturated oxygen therapy (SSO2). This therapy was chosen due to its potential to enhance myocardial salvage, particularly in severe MI cases like the patient. The report meticulously details the patient's clinical course, including the diagnostic procedures and the rationale behind opting for SSO2 therapy. It highlights the significant improvements observed post-therapy: enhanced left ventricular (LV) function and a remarkable reduction in the size of the LV apical aneurysm. These outcomes suggest a direct benefit of SSO2 in reducing myocardial damage. Finally, the report discusses the broader implications of these findings. It underscores the potential of optimized SSO2 therapy in clinical settings, particularly for patients with anterior MI. The case exemplifies how advanced therapeutic interventions like SSO2 can play a pivotal role in improving clinical outcomes post-MI, thereby advocating for its consideration in similar clinical scenarios.